New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 29, 2014
08:32 EDTUNH, THCUnitedHealthcare, Tenet renew network relationship
UnitedHealthcare, a UnitedHealth Group company (UNH), and Tenet Healthcare Corporation (THC) have completed a new, three-year agreement providing UnitedHealthcare’s Commercial and Medicare Advantage members with in-network access to Tenet’s 79 hospitals, 193 outpatient centers and more than 1,800 employed physicians throughout the country. The new agreement is effective August 1, 2014. “This agreement provides consumers uninterrupted access to quality care in their local communities,” said Dan Rosenthal, president of UnitedHealthcare Networks. “We are pleased to renew this national contract with Tenet which gives our members access to providers focused on driving care improvements and offers competitive reimbursement rates, a portion of which, importantly, rewards Tenet for achieving certain quality measures.”
News For UNH;THC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 18, 2015
07:22 EDTTHCUBS to hold a conference
Global Healthcare Conference is being held in New York on May 18-20 with webcasted company presentations to begin on May 18 at 8 am; not all company presentations may be webcasted. Webcast Link
May 14, 2015
08:02 EDTTHCHealthcare Facilities sector upgraded to Attractive at Morgan Stanley
Subscribe for More Information
07:33 EDTUNHUnitedHealth would consider Optum spinoff if benefits erode, says UBS
Subscribe for More Information
May 11, 2015
07:40 EDTUNHFocus on Vertex will shift to pricing after Orkambi FDA meeting, WSJ says
An FDA advisory committee that meets Tuesday to decide whether to recommend approval of Vertex’s Orkambi will be closely watched by health insurers and pharmacy-benefit managers concerned that the experimental cystic-fibrosis drug will be high-priced, said The Wall Street Journal. Vertex hasn’t announced a price, but analyst at JPMorgan predict the drug will have a wholesale price of about $287,000 annually per patient. Publicly traded PBM owners include Catamaran (CTRX), which is being acquired by UnitedHealth (UNH), CVS Health (CVS) and Express Scripts (ESRX). Reference Link
07:13 EDTUNHUnitedHealth management to meet with UBS
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use